No Data
No Data
Earnings Troubles May Signal Larger Issues for Modern Chinese Medicine Group (HKG:1643) Shareholders
A lackluster earnings announcement from Modern Chinese Medicine Group Co., Ltd. (HKG:1643) last week didn't sink the stock price. We think that investors are worried about some weaknesses underlying
現代中藥集團:2023年報
Have Insiders Sold Modern Chinese Medicine Group Shares Recently?
We wouldn't blame Modern Chinese Medicine Group Co., Ltd. (HKG:1643) shareholders if they were a little worried about the fact that Xinlei Sun, the Executive Chairman recently netted about HK$18m sell
Modern Chinese Medicine Group (01643.HK) profit before tax fell 45.1% to 68.3 million yuan in 2023
Gelonghui March 22 | Modern Chinese Medicine Group (01643.HK) announced that for the year ended December 31, 2023, the Group recorded revenue of approximately RMB 344.1 million in 2023, a decrease of approximately RMB 55.6 million or 13.9% compared with the fiscal year ending 2022. The decline in revenue was mainly due to changes in government policies, which led to a decrease in orders from dealers. Profit before tax decreased by about 45.1% from about RMB 124.3 million in 2022 to about RMB 68.3 million as of 2023, mainly due to changes in government policies, the decrease in dealer orders
MODERN CHI MED: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Modern Chinese Medicine Group (01643.HK) plans to hold a board meeting on March 22 to consider and approve the annual results
Gelonghui, March 13, 丨 Modern Chinese Medicine Group (01643.HK) announced that the company will hold a board meeting on March 22, 2024 (Friday). The agenda includes considering and approving the annual results of the company and its subsidiaries for the year ended 31 December 2023 and considering payment of a final dividend proposal (if any).
No Data